The Pharma Letter

Executive Q&A

Executive Q&A: Bob Radie, chief executive and president of Egalet

In an interview with The Pharma Letter, Egalet Corporation’s chief executive Bob Radie discusses the company’s lead product Egalet-001, its proprietary technology work and collaboration with Shionogi.

Latest Pharmaceutical News

Latest Biotechnology News

Latest Generics News

Boardroom

Mergers & Acquisitions

Pharma M&A deals in 2013 down, but values marginally higher

Pharma M&A deals in 2013 down, but values marginally higher

Merger and acquisition activity in the pharmaceutical, biotechnology and generic drugs sectors continued steadily in 2013, but the days of mega mergers are clearly over as the number of giant players has diminished.

Back to top